Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Corsetti

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Atherosclerosis|June 1, 2005
Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Atherosclerosis|November 9, 2004
Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Clinical Biochemistry|September 6, 2011
Glycerol as a reference material for fecal fat quantitation using low-resolution time domain ¹H NMR spectroscopyJames P Corsetti, Judy Sterry, Manisha Sakpal, et al.
European Journal of Clinical Investigation|April 24, 2010
Inflammation reduces HDL protection against primary cardiac riskJames P Corsetti, Ron T Gansevoort, Charles E Sparks, et al.
Atherosclerosis|January 12, 2007
NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patientsJames P Corsetti, Dan Ryan, Arthur J Moss, et al.
Atherosclerosis|October 26, 2005
Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammationJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Clinical Chemistry|May 20, 2006
High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patientsJames P Corsetti, David L Rainwater, Arthur J Moss, et al.
Plos One|June 23, 2012
Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive proteinJames P Corsetti, Stephan J L Bakker, Charles E Sparks, et al.
Journal of Clinical Lipidology|September 1, 2016
Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease studyJames P Corsetti, Ron T Gansevoort, Stephan J L Bakker, et al.
The American Journal of Medicine|November 3, 2007
Chronic kidney disease prevalence and rate of diagnosisTimothy P Ryan, James A Sloand, Paul C Winters, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Atherosclerosis|June 1, 2005
Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Atherosclerosis|November 9, 2004
Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Clinical Biochemistry|September 6, 2011
Glycerol as a reference material for fecal fat quantitation using low-resolution time domain ¹H NMR spectroscopyJames P Corsetti, Judy Sterry, Manisha Sakpal, et al.
European Journal of Clinical Investigation|April 24, 2010
Inflammation reduces HDL protection against primary cardiac riskJames P Corsetti, Ron T Gansevoort, Charles E Sparks, et al.
Atherosclerosis|January 12, 2007
NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patientsJames P Corsetti, Dan Ryan, Arthur J Moss, et al.
Atherosclerosis|October 26, 2005
Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammationJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Clinical Chemistry|May 20, 2006
High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patientsJames P Corsetti, David L Rainwater, Arthur J Moss, et al.
Plos One|June 23, 2012
Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive proteinJames P Corsetti, Stephan J L Bakker, Charles E Sparks, et al.
Journal of Clinical Lipidology|September 1, 2016
Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease studyJames P Corsetti, Ron T Gansevoort, Stephan J L Bakker, et al.
The American Journal of Medicine|November 3, 2007
Chronic kidney disease prevalence and rate of diagnosisTimothy P Ryan, James A Sloand, Paul C Winters, et al.
Pageof 4